These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2130305)

  • 21. [Disturbances of magnesemia in chronic kidney diseases].
    Popovi0c EP; Susa S; Savić B
    Vojnosanit Pregl; 1969 Apr; 26(4):186-90. PubMed ID: 5194611
    [No Abstract]   [Full Text] [Related]  

  • 22. [Disturbances of magnesemia in chronic kidney disease].
    Popovíc EP; Susa S; Savić B
    Vojnosanit Pregl; 1969 Apr; 26(4):186-90. PubMed ID: 5195700
    [No Abstract]   [Full Text] [Related]  

  • 23. [Function of terminal complement complex and control protein in renal disease (renal localization and serum levels of S protein, and detection of the SC5b-9 complex)].
    Kojima H; Ohi H; Seki M; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Nov; 28(11):1449-56. PubMed ID: 2434699
    [No Abstract]   [Full Text] [Related]  

  • 24. [Classification of the stage of kidney failure in chronic glomerulonephritis].
    Peleshchuk AP; Pyrig LA; Mel'man NIa; Romaniuk GV; Frenkel' LA
    Vrach Delo; 1980 Oct; (10):74-7. PubMed ID: 7434712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacokinetics of ampicillin in patients with kidney allograft].
    Iarmolinskii IS; Vasina TA; Goriainov VA
    Antibiotiki; 1971 Jul; 16(7):661-3. PubMed ID: 4945581
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pathogenetic significance of coagulopathies in the stage of chronic renal insufficiency of chronic glomerulonephritis].
    Belitskaia GA
    Vrach Delo; 1972 Dec; 12():81-5. PubMed ID: 4659226
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
    Ershova LI; Gorbunova NA
    Ter Arkh; 1997; 69(7):46-50. PubMed ID: 9424758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII activity in chronic renal disease.
    Wegmüller E; Grüninger U; Furlan M; Beck EA; Hodler J; Reubi FC
    Nephron; 1981; 28(4):157-62. PubMed ID: 6795517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
    Ishihara T; Yokota N; Hisanaga S; Fujimoto S; Hirayama N; Kato J; Kitamura K; Eto T
    Clin Nephrol; 1999 Aug; 52(2):119-23. PubMed ID: 10480223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Globin synthesis by nucleated erythroid cells in chronic glomerulonephritis.
    Riabov SI; Kozlov VV
    Nephron; 1978; 20(2):90-4. PubMed ID: 622214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapidly progressive glomerulonephritis in a renal transplant.
    Fernández Lucas M; Rivera M; Marcén R; Mampaso F; Gonzalo A; Quereda C; Ortuño J
    Transplant Proc; 1994 Dec; 26(6):3693-4. PubMed ID: 7998323
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapidly progressive glomerulonephritis complicating primary AL amyloidosis and multiple myeloma.
    Crosthwaite A; Skene A; Mount P
    Nephrol Dial Transplant; 2010 Aug; 25(8):2786-9. PubMed ID: 20042399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in crescentic glomerulonephritis: a single-center experience.
    Ozturk R; Yenigun EC; Dede F; Koc E; Turgut D; Piskinpasa SV; Ozkayar N; Odabas AR
    Iran J Kidney Dis; 2015 Jan; 9(1):31-8. PubMed ID: 25599734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Elderly Patients with Rapidly Progressive Glomerulonephritis.
    Hruskova Z; Tesar V
    Blood Purif; 2018; 45(1-3):213-217. PubMed ID: 29478046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaemia in patients with chronic renal disease.
    Voglová-Lakosilová J; Chrobák L; Erben J; Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1978; 21(3):311-20. PubMed ID: 283544
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG; Petrun' NM; Pyrig LA; Mel'man NIa
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic T-lymphocyte activation in chronic renal failure: a study of hemodialysis, CAPD and pre-dialysis patients.
    Caruana RJ; Leffell MS; Lobel SA; Campbell HT; Cheek PL
    Int J Artif Organs; 1992 Feb; 15(2):93-8. PubMed ID: 1555882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperchloraemia: a non-specific finding in chronic renal failure.
    Enia G; Catalano C; Zoccali C; Maggiore Q; Poon TF; Ward MK; Kerr DN
    Nephron; 1985; 41(2):189-92. PubMed ID: 4047277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.